Addus HomeCare (NASDAQ:ADUS) Stock: Insider Brian Poff Sells 6,644 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Brian Poff sold 6,644 shares of the stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $124.72, for a total value of $828,639.68. Following the transaction, the executive vice president directly owned 57,048 shares of the company’s stock, valued at approximately $7,115,026.56. The trade was a 10.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $125.49 on Thursday. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.64. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $131.59. The business has a 50 day simple moving average of $118.19 and a two-hundred day simple moving average of $107.10. The stock has a market capitalization of $2.34 billion, a PE ratio of 20.91, a P/E/G ratio of 1.66 and a beta of 0.75.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.79 by $0.04. The business had revenue of $387.74 million for the quarter, compared to analysts’ expectations of $388.72 million. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.56 EPS. On average, research analysts predict that Addus HomeCare Corporation will post 6.41 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. Bank of America downgraded shares of Addus HomeCare from a “buy” rating to a “neutral” rating and decreased their price target for the company from $140.00 to $125.00 in a research note on Monday, September 14th. Truist Financial lifted their price objective on shares of Addus HomeCare from $135.00 to $148.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Royal Bank Of Canada boosted their target price on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Citigroup downgraded shares of Addus HomeCare from a “market outperform” rating to a “neutral” rating in a report on Monday, September 14th. Finally, UBS Group upped their target price on shares of Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, November 5th. Seven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average target price of $134.70.

Institutional Investors Weigh In On Addus HomeCare

Institutional investors have recently modified their holdings of the stock. Private Wealth Asset Management LLC purchased a new position in shares of Addus HomeCare in the 3rd quarter worth approximately $187,000. Private Advisor Group LLC raised its holdings in Addus HomeCare by 15.5% during the 3rd quarter. Private Advisor Group LLC now owns 2,940 shares of the company’s stock valued at $325,000 after buying an additional 394 shares during the period. Boston Partners raised its holdings in Addus HomeCare by 18.0% during the 3rd quarter. Boston Partners now owns 290,332 shares of the company’s stock valued at $32,222,000 after buying an additional 44,279 shares during the period. Global Retirement Partners LLC raised its holdings in Addus HomeCare by 270.4% during the 3rd quarter. Global Retirement Partners LLC now owns 900 shares of the company’s stock valued at $99,000 after buying an additional 657 shares during the period. Finally, Hantz Financial Services Inc. lifted its position in Addus HomeCare by 21.3% in the third quarter. Hantz Financial Services Inc. now owns 620 shares of the company’s stock worth $69,000 after buying an additional 109 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare News Roundup

Investors following ADUS have been watching these news items:

• Positive Sentiment: TD Cowen raised its price target to $145 and reiterated a Buy rating; Wall Street Zen also upgraded the stock to Strong Buy. The company’s latest reported quarterly EPS of $1.83 topped the $1.79 consensus, while revenue grew 7% year over year, though it narrowly missed estimates.
• Neutral Sentiment: Addus plans to participate in the 2026 Stephens Annual Investment Conference. The announcement offers investor access but provides no new operating or financial guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
• Negative Sentiment: Several executives sold shares on Nov. 6, and CEO R. Allison sold 98,958 shares on Nov. 9 for about $12.2 million, reducing his stake by 35.08%. Five executive vice presidents also sold a combined 32,697 shares. The volume of insider selling may weigh on investor sentiment, though sales alone do not establish a negative view of the company. CEO sale filing Article: EVP share sale

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.